Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine and docetaxel in patients with persistent, recurrent, or metastatic head and neck cancer has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-28